Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARPi-PANC
2021-003042-20Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of niraparib in pancreatic cancer (PC), sponsored by Centre Léon Bérard. Primary endpoint: Objective response rate. Started Apr 2022; status: completed.
02
Drugs
niraparib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2021-003042-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003042-20.